[1] . Habibina MR:JAMA 233:1073,1975.
[2] . Pressman D et al:Cancer 6:619,1953.
[3] . Bale WF et al:Proc Soc EXP Biol Med 89:564,1955.
[4] . Goldenberg et al:N Engl J Med 298:1384,1978.
[5] . Wade N:Science 208(4445):692,1980.
[6] . Levine G et al:J Nucl Med 21:570,1980.
[7] . Moshakis V et al:J Clin Pathol 34:314,1981.
[8] . Denardo S et al:Procceoings of the Third World Congress of Nuclear Medicine and Biology 1:1,1982.
[9] . Pimm MV et al:Cancer Immunol Immunothcr 12:125~134,1982.
[10] . Fairweather DS et al:Lancet 2:660,1982.
[11] . Mach JR et al:Immunology Today P239,December 1981.
[12] . Key ME et al:J Immunol 130:1451,1983.
[13] . Morrison RT et al:Preceedings of the Third World Congress of Nuclear Medicine and Biology 1-1 p186,1982.
[14] . Primus FJ:Cancer Res 40:497,1980.
[15] . Levine G et al:J Nucl Med 22:35,1981.
[16] . Khaw B et al:J nucl med 23:1011,1982.
[17] . Cox PH et al:Progress in Radiopharmacology 3.
[18] . Sturman MF:J Nucl Med 16:77, 1975.
[19] . Kabalka GW et al:J Nucl Med 22:908,1981.
[20] . Katzenellenbogen JA et al:J Nucl Med 23:411,1982.
[21] . Mcelvany KD et al:J Nucl Med 23:420,1982.
[22] . Gatley SP et al:J Nucl Med 22:459,1981.
[23] . Spencer RP et al:Radiopharmaceuticals,1981.
[24] . Krohn KA:J Nucl Med 21:593,1980.
[25] . Katzenellenbogen JA et al:J Nucl Med 21:550,1980.
[26] . Arew SD:Int J Nucl Med Bioi 8:217,1981.